Pages that link to "Q73888023"
Jump to navigation
Jump to search
The following pages link to Prognostic Factors in Patients with Localized Ewing’s Sarcoma: The effect on survival of actual received drug dose intensity and of histologic response to induction therapy (Q73888023):
Displaying 8 items.
- Primary malignant bone tumors—recent developments (Q33274167) (← links)
- High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). (Q34539534) (← links)
- Clinical and cellular pharmacology in relation to solid tumours of childhood (Q35202886) (← links)
- The clinical use of biomarkers as prognostic factors in Ewing sarcoma (Q35957979) (← links)
- Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study (Q43873502) (← links)
- Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone (Q46260307) (← links)
- Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). (Q53390484) (← links)
- Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005 (Q84110858) (← links)